Sight Sciences’ TearCare Shows Lasting Dry Eye Relief in Sahara Phase III Trial
Latest data shows TearCare delivers nearly two years of sustained dry eye relief after only two treatments. The Phase III…
Stuart Therapeutics Unveils Phase III Results for Novel Dry Eye Candidate
ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…
latest posts
